Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent, Blood, vol.84, pp.4384-4389, 1994. ,
Purification and characterization of placental protein 5, Biochem Biophys Res Commun, vol.150, pp.483-90, 1988. ,
Partial characterization of matrixassociated serine protease inhibitors from human skin cells, J Invest Dermatol, vol.104, pp.379-83, 1995. ,
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2, Arch Biochem Biophys, vol.335, pp.82-92, 1996. ,
Immunofluorometric demonstration and quantification of placental protein 5 in the absence of pregnancy, Clin Chem, vol.34, pp.1591-1594, 1988. ,
Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast, Int J Cancer, vol.24, pp.6-10, 1979. ,
Placental protein 5 is related to blood coagulation and fibrinolytic systems, Life Sci, vol.30, pp.1885-91, 1982. ,
Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization, Placenta, vol.19, pp.217-240, 1998. ,
Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry, J Lab Clin Med, vol.111, pp.249-56, 1988. ,
Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts, Placenta, vol.23, pp.145-53, 2002. ,
Demonstration of a tissue factor pathway inhibitor-2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas, Biol Reprod, vol.68, pp.1888-94, 2003. ,
cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2, J Biochem, vol.116, pp.939-981, 1994. ,
Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Blood, vol.100, p.486, 2002. ,
Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6, DNA Cell Biol, vol.15, pp.947-54, 1996. ,
Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts, Arch Biochem Biophys, vol.317, pp.311-315, 1995. ,
Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2, Arterioscler Thromb Vasc Biol, vol.18, pp.40-46, 1998. ,
Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes, Febs Lett, vol.481, pp.31-37, 2000. ,
Gene expression of proteases and protease inhibitors in the human ciliary epithelium and ODM-2 cells, Exp Eye Res, vol.65, pp.289-99, 1997. ,
Urothelial function reconsidered: a role in urinary protein secretion, Proc Natl Acad Sci, vol.98, pp.154-163, 2001. ,
,
Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells, J Vasc Res, vol.39, pp.340-52, 2002. ,
Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels, Arterioscler Thromb Vasc Biol, vol.22, pp.218-242, 2002. ,
Simultaneous expression of tissue factor, tissue factor pathway inhibitor 1 and 2 in blood monocytesderived macrophages, Circulation, vol.98, p.525, 1998. ,
Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-102, 1999. ,
Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin, Arch Biochem Biophys, vol.370, pp.112-120, 1999. ,
Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2, Biochem Biophys Res Commun, vol.276, pp.1286-94, 2000. ,
Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes, Blood, vol.93, pp.3418-3449, 1999. ,
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis, J Clin Invest, vol.107, pp.1117-1143, 2001. ,
Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR, Thromb Res, vol.105, pp.217-240, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-02127753
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays, Proc Natl Acad Sci, vol.95, pp.14470-14475, 1998. ,
Deletion mapping of plasminogen activator inhibitor, type I (PLANH1) and beta-glucuronidase (GUSB) in 7q21-q22, Cytogenet Cell Genet, vol.56, pp.152-155, 1991. ,
Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor, Proc Natl Acad Sci, vol.91, pp.3353-3360, 1994. ,
Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene, Biochim Biophys Acta, vol.1517, pp.430-435, 2001. ,
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb Res, vol.109, pp.207-222, 2003. ,
Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas, Oncogene, vol.21, pp.921-929, 2002. ,
The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter, J Biol Chem, vol.278, pp.6787-94, 2003. ,
Inducible expression of a constitutively active mutant of mitogen-activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation, J Biol Chem, vol.277, pp.3576-84, 2002. ,
Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity, J Exp Med, vol.196, pp.605-622, 2002. ,
Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2, Thromb Haemost, vol.83, pp.141-148, 2000. ,
Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1063, 2003. ,
Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-851, 2003. ,
cDNA cloning and tissue distribution of the rat ortholog of tissue factor pathway inhibitor-2, Thromb Haemost, vol.88, pp.356-363, 2002. ,
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor, Biochemistry, vol.35, pp.266-72, 1996. ,
Inhibitory properties of human recombinant Arg24-> Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2), Thromb Res, vol.94, pp.147-52, 1999. ,
3D modeling of human TFPI-2 kunitz-type protease inhibitor complexed with human plasmin, Thromb Res, vol.111, pp.197-205, 2003. ,
Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis, Genomics, vol.35, pp.267-275, 1996. ,
Tissue factor pathway inhibitor-2 (TFPI-2) deficiency is compatible with development, growth to adulthood, and fertility. Résumé de l, Blood, vol.100, p.486, 2002. ,
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001. ,
In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, Clin Exp Metastasis, vol.18, pp.239-283, 2000. ,
Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells, J Biol Chem, vol.275, pp.35565-35574, 2000. ,
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI, Int J Cancer, vol.76, pp.749-56, 1998. ,
Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro, Int J Oncol, vol.18, pp.127-158, 2001. ,
Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metastasis, vol.18, pp.303-311, 2000. ,
Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo, Gynecol Oncol, vol.83, pp.325-358, 2001. ,
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor, J Clin Invest, vol.104, pp.1213-1234, 1999. ,
Chromosome 7q deletions : observations on 13 malignant tumors, Cancer Genet Cytogenet, vol.67, pp.123-128, 1993. ,
A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas, Int J Oncol, vol.19, pp.591-598, 2001. ,
Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells, J Biol Chem, vol.274, pp.5379-84, 1999. ,
Developmental biology: vasculogenesis is a wreck without RECK, Curr Biol, vol.12, pp.209-220, 2002. ,
Metalloproteinase inhibitors: biological actions and therapeutic opportunities, J Cell Sci, vol.115, pp.3719-3746, 2002. ,